Truist Financial Corp Has $60.59 Million Holdings in McKesson Corporation $MCK

Key Points

• Truist Financial Corp raised its McKesson stake by 2.4% in Q4 to 73,869 shares worth $60.59 million, roughly 0.06% of the company.
• McKesson beat Q results (EPS $9.34 vs. $9.19) and set FY2026 guidance of 38.80–39.20 EPS, near the Street's ~39.02 consensus; market cap is about $99 billion.
• Insiders have trimmed positions recently—EVP Michele Lau sold 2,725 shares (~$2.70M) and insiders sold 3,592 shares (~$3.52M) over three months, leaving insiders with just 0.08% ownership.

Truist Financial Corp lifted its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 2.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 73,869 shares of the company's stock after purchasing an additional 1,729 shares during the quarter. Truist Financial Corp owned approximately 0.06% of McKesson worth $60,594,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. Obsidian Personal Planning Solutions LLC boosted its position in McKesson by 2.9% in the third quarter. Obsidian Personal Planning Solutions LLC now owns 426 shares of the company's stock valued at $346,000 after buying an additional 12 shares in the last quarter. Berkshire Asset Management LLC PA boosted its position in McKesson by 4.6% in the third quarter. Berkshire Asset Management LLC PA now owns 294 shares of the company's stock valued at $227,000 after buying an additional 13 shares in the last quarter. Norden Group LLC boosted its position in McKesson by 4.3% in the fourth quarter. Norden Group LLC now owns 317 shares of the company's stock valued at $260,000 after buying an additional 13 shares in the last quarter. Wealthcare Advisory Partners LLC boosted its position in McKesson by 0.7% in the fourth quarter. Wealthcare Advisory Partners LLC now owns 1,873 shares of the company's stock valued at $1,536,000 after buying an additional 13 shares in the last quarter. Finally, Red Door Wealth Management LLC boosted its position in McKesson by 3.8% in the fourth quarter. Red Door Wealth Management LLC now owns 358 shares of the company's stock valued at $293,000 after buying an additional 13 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company's stock.

Insider Transactions at McKesson

In other news, EVP Michele Lau sold 2,725 shares of the company's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the transaction, the executive vice president owned 3,247 shares of the company's stock, valued at $3,214,530. This represents a 45.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Maria Martinez sold 349 shares of the company's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $939.87, for a total value of $328,014.63. Following the transaction, the director directly owned 301 shares in the company, valued at $282,900.87. This trade represents a 53.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 3,592 shares of company stock worth $3,518,555. 0.08% of the stock is owned by insiders.

McKesson Price Performance

Shares of McKesson stock opened at $808.15 on Tuesday. The firm has a market cap of $98.99 billion, a P/E ratio of 23.24, a P/E/G ratio of 1.18 and a beta of 0.35. The firm has a 50 day simple moving average of $894.86 and a 200 day simple moving average of $860.34. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. McKesson's revenue for the quarter was up 11.4% compared to the same quarter last year. During the same quarter last year, the business posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts expect that McKesson Corporation will post 39.02 EPS for the current year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be paid a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson's dividend payout ratio is 9.43%.

Analyst Upgrades and Downgrades

A number of research firms have commented on MCK. William Blair began coverage on shares of McKesson in a research report on Tuesday, April 28th. They issued an "outperform" rating on the stock. Raymond James Financial set a $970.00 price target on McKesson in a report on Thursday, March 5th. Bank of America dropped their price target on McKesson from $1,040.00 to $1,000.00 and set a "buy" rating for the company in a report on Monday, April 6th. JPMorgan Chase & Co. raised their price target on McKesson from $983.00 to $1,107.00 and gave the company an "overweight" rating in a report on Tuesday, February 10th. Finally, Robert W. Baird set a $968.00 price target on McKesson in a report on Wednesday, January 14th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, McKesson presently has an average rating of "Moderate Buy" and a consensus price target of $972.27.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.